+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Opioid distributors soar after reportedly offering $18 billion to settle a swath of drug crisis lawsuits

Oct 16, 2019, 18:43 IST

In this Aug. 9, 2016, file photo, a bag of 4-fluoro isobutyryl fentanyl which was seized in a drug raid is displayed at the Drug Enforcement Administration (DEA) Special Testing and Research Laboratory in Sterling, Va.AP

Advertisement

Opioid distributors AmerisourceBergen, Cardinal Health, and McKesson all surged in early Wednesday trading after The Wall Street Journal reported the companies are in talks to settle state and local lawsuits blaming them for the US drug epidemic.

AmerisourceBergen and McKesson traded roughly 7% higher early Wednesday. Cardinal Health traded as much as 8% higher.

The three companies are looking to settle the litigation with a collective $18 billion payment over 18 years, sources told WSJ. The settlement would serve as a sweeping resolution to a collection of lawsuits and keep the drugmakers from bankruptcy.

OxyContin producer Purdue Pharma was forced to file for bankruptcy in mid-September to pay a settlement valued between $10 billion and $12 billion.

Advertisement

Read more: BlackRock's bond chief oversees $1.7 trillion and sleeps only 4 hours a night. He outlines his 2 favorite opportunities in a market being reshaped by tech and shifting demographics.

The news follows Johnson & Johnson settling two Ohio opioid lawsuits for $20.4 million on October 1. The deal allows the pharmaceutical giant to skip an upcoming federal trial looking to hold health care firms accountable for the epidemic.

AmerisourceBergen, Cardinal Health, and McKesson are all scheduled to join the federal trial in Ohio Monday. The case is set to serve as a critical precedent in other lawsuits against opioid producers and distributors.

Opioids contributed to more than 400,000 overdose fatalities in the US from 1999 to 2017, according to the US Centers for Disease Control and Prevention. More than 70,000 people died of drug overdoses in 2017 alone, with 68% of the fatalities involving prescription or illicit opioids.

Now read more markets coverage from Markets Insider and Business Insider:

Advertisement

Warren Buffett reportedly wants the Fed's permission to boost Berkshire's stake in Bank of America beyond 10%

Goldman Sachs says it absorbed an $80 million write-down after WeWork's IPO disaster

Wells Fargo sees more adviser retirements after an 'enthusiastic' response to its next-gen handover payouts

Featured Digital Health Articles:
- Telehealth Industry: Benefits, Services & Examples
- Value-Based Care Model: Pay-for-Performance Healthcare
- Senior Care & Assisted Living Market Trends
- Smart Medical Devices: Wearable Tech in Healthcare
- AI in Healthcare
- Remote Patient Monitoring Industry: Devices & Market Trends

Next Article